PFE - Pfizer Valneva post Phase 2 booster data for Lyme disease vaccine
2023-09-07 06:56:20 ET
More on Valneva
- Seeking Alpha’s Quant Rating on Valneva
- Historical earnings data for Valneva
- Financial information for Valneva
- Valneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Race
- Valneva falls as FDA extends review of chikungunya vaccine
For further details see:
Pfizer, Valneva post Phase 2 booster data for Lyme disease vaccine